A Trial to Establish the Feasibility of Combining Either the Tyrosine Kinase Inhibitor AC220,CXCR4 Inhibitor Plerixafor or HSP90 Inhibitor Ganetespib With Chemotherapy in Older Patients With Acute Myeloid Leukaemia and High Risk Myelodysplastic Syndrome.
Clinical trial NCT01236144 · COMPLETED
Trial details
- NCT number
- NCT01236144
- Sponsor
- Cardiff University
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-04-01
- Primary completion
- 2013-12-01
- Enrollment
- 113
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.